10-K Decoder · All companies

AbCellera Biologics Inc.

ABCL · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Feb 2026

Open the dashboardInfographicSummary

FY2025 key figures

$FY2025FY2024Change
Revenue$75.1M$28.8M+161%
Operating income−$217M−$315M+31.0%
Net income−$146M−$163M+10.1%

Latest quarter: Q3 2026

Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 9, 2026

$Q3 2026Year earlierChange
Revenue$10.6M$9.00M+17.8%
Operating income−$53.3M−$76.3M+30.1%
Net income−$40.8M−$57.1M+28.5%

Q3 2026 dashboardQ3 2026 infographic

Questions

What was AbCellera's revenue in FY2025?
$75.1M in FY2025 (Fiscal year ended Dec 31, 2025), +161% vs $28.8M a year earlier, per its 10-K filed Feb 2026.
Was AbCellera profitable in FY2025?
No: net income was −$146M and operating income −$217M in FY2025.
What was AbCellera's revenue in Q3 2026?
$10.6M (+17.8% vs a year earlier), per its Form 10-Q filed Nov 9, 2026.